Why Orthopedic Billing Accuracy Is a Valuation Lever for PE-Backed Practices in 2026

Orthopedic billing services are the specialized revenue cycle functions that manage claim submission, coding accuracy, prior authorization, global period tracking, and implant capture for orthopedic surgical practices – the clinical and administrative infrastructure that determines how much of the revenue a surgeon generates actually reaches the practice's bank account.

Private equity has steadily reshaped the orthopedic practice landscape over the past decade. A December 2025 peer-reviewed study from NYU Langone Orthopedic Hospital describes the rising PE influence as a fundamental transformation in how orthopedic surgical practices are structured, financed, and operated – one that is no longer optional for surgeons evaluating their long-term options [1].

What changed in 2026 is the pressure on the financial performance that PE investment depends on. For PE portfolio operations teams and orthopedic CFOs, the revenue cycle has moved from a back-office function to a board-level financial variable.

According to a peer-reviewed analysis published in the Journal of Orthopaedic Experience & Innovation, orthopedics remains one of the most active segments of the healthcare services industry for PE strategic partnerships – driven by high demand for orthopedic care against a relatively low supply of orthopedic surgeons, a supply and demand imbalance that underpins long-term sustainable growth in a highly fragmented clinical specialty [2].

The investment thesis is durable. For the orthopedic groups that partner with PE, the implication is immediate: financial performance is now evaluated through a different lens than it was for an independent practice.

The EBITDA multiple changes the billing conversation entirely.

Healthcare M&A advisors and investment bankers widely report EBITDA multiples in the range of 7 to 10 times for multi-surgeon orthopedic groups in 2025-2026, with platform-level practices commanding the upper range [3]. At those multiples, billing accuracy is not just an operational concern – it is a transaction variable.

Consider a concrete example. A multi-surgeon orthopedic group generates $8 million in annual revenue at a 20% EBITDA margin – $1.6 million in EBITDA. At a 7x multiple, that practice is worth $11.2 million. At 9x, $14.4 million.

Now introduce systematic billing leakage: global period violations, hardware not captured, prior authorization denials on arthroplasty, place-of-service mismatches between ASC and hospital outpatient settings. If those gaps suppress net collections by 4-5%, the EBITDA contraction multiplies at the same rate as the revenue improvement.

A $200,000 annual improvement in net collections does not add $200,000 to enterprise value. It adds $1.4 to $2 million at a 7-10x multiple.

That is not a billing metric. That is a transaction outcome – and it is why orthopedic billing accuracy has become a PE board-level conversation in 2026.

Three regulatory changes took effect on January 1, 2026. Each is consequential for medical billing for orthopedics in isolation. Together, they are creating a reimbursement environment that standard billing workflows were not built for.

The TEAM Model – Mandatory Episode Accountability for Joint Replacement and Spine

The Transforming Episode Accountability Model (TEAM) is a mandatory, five-year, episode-based payment model launched January 1, 2026. Acute care hospitals in selected geographic regions are financially accountable for the full cost of care during a 30-day episode following specific surgical procedures [4]:

• Lower extremity joint replacement (LEJR) – hip and knee arthroplasty
• Spinal fusion
• Surgical hip femur fracture treatment

Under TEAM, hospitals own every dollar of Medicare Parts A and B spending during that 30-day window. Episode costs exceeding the CMS target price are absorbed by the hospital. Costs below the target generate shared savings.

For orthopedic groups whose surgical volumes run through TEAM-participating hospitals, this creates a direct financial link between coding accuracy, discharge documentation, and the hospital's performance – and by extension, the facility relationships that drive surgical access and referrals.

3Gen has written about the TEAM Model's implications for home health agencies separately – How Will the CMS TEAM Model Impact Home Health Billing? The billing implications differ by care setting, but the episode accountability logic is the same.

The -2.5% PFS Efficiency Adjustment – Compressing Surgical Reimbursement

The CY 2026 Physician Fee Schedule Final Rule (CMS-1832-F) applied a -2.5% efficiency adjustment to work relative value units across most non-time-based procedural and diagnostic services – including the high-volume orthopedic surgical procedures that constitute the majority of revenue for most orthopedic groups [5].

Lower base reimbursement means every unresolved denial now represents a higher percentage of recoverable revenue than it did before the cut. Best-performing orthopedic billing services maintain denial rates below 5% for surgical revenue mixes. Practices operating above that threshold feel the PFS cut and the denial rate compounding together.

CMS-0057-F Prior Authorization Reform – 7 Days and Public Transparency

CMS-0057-F, effective January 1, 2026, requires Medicare Advantage organizations, Medicaid managed care plans, and Qualified Health Plan issuers to send standard prior authorization decisions within 7 calendar days (urgent: 72 hours). The rule also mandates that these payers publicly report prior authorization metrics – approval rates, denial rates, and average decision times – annually beginning in 2026 [6].

For orthopedic practices, two implications are immediate:

• Documentation completeness at submission: The 7-day window compresses the timeframe for follow-up. Clinical documentation supporting prior authorization for total joint arthroplasties and spine procedures must be complete at the first request.
• Payer transparency: The public reporting requirement creates, for the first time, a searchable record of how each MA plan adjudicates orthopedic prior authorizations. That data will inform payer contract negotiations in ways it currently cannot.

The revenue leakage points in medical billing for orthopedics are specific, technical, and consistently underestimated by practices that have not mapped them against actual payer remittance data. These are not generic billing errors – they are orthopedic-specific failure points that compound into EBITDA suppression at scale.

The four highest-impact leakage categories:

• Global period violations: Major orthopedic surgical procedures carry 90-day global periods. Services rendered during that window — routine post-operative follow-up, incision checks, casting adjustments — are bundled into the original surgical payment and cannot be billed separately unless a distinct new condition or complication arises. Misapplying the global period in either direction creates both compliance risk and lost revenue.
• Implant and hardware not captured: Joint replacement, spinal fusion, and fracture fixation involve implants and fixation hardware that must be separately identified, coded, and billed against the appropriate payer contract. For high-volume orthopedic groups performing hundreds of arthroplasties annually, systematic implant capture gaps produce material revenue leakage that never appears in a denial report – because the claim was paid, just at the wrong amount.
• Place-of-service mismatches: As orthopedic procedures increasingly shift from hospital outpatient departments to ASC settings, billing rules for the same procedure vary depending on the care setting. Misapplication of place-of-service (POS) codes generates underpayments that accumulate silently across billing cycles.
• Prior authorization misalignment for arthroplasty: Under the new 7-day decision window, incomplete documentation at the authorization request stage generates avoidable denials for total joint arthroplasties and spine procedures. Practices without payer-specific authorization templates calibrated to each MA plan's requirements will face a predictable increase in prior auth-driven denials.

The distinction between standard RCM and specialty-calibrated orthopedic billing services is not about how many specialties a billing partner serves – it is about whether orthopedic-specific coding logic, global period rules, implant billing protocols, and payer-specific arthroplasty authorization requirements are built into the daily workflow from day one.

3Gen Consulting brings specialty depth across 40+ specialties, which means the coding and reimbursement intelligence from adjacent specialties – surgical, procedural, ASC-based – informs the orthopedic workflow in ways a single-specialty billing operation cannot match.

For PE portfolio operations teams evaluating a new orthopedic acquisition or assessing an existing platform, the following five-step process identifies billing-driven EBITDA leakage and quantifies the recovery opportunity:

• Baseline net collection rate by payer and procedure: Pull 12 months of remittance data and calculate actual received versus contracted expected for top 10 procedures across all payers. The gap between expected and actual is the underpayment exposure.
• Global period audit: Review post-operative claims across the prior 12 months. Identify claims billed separately during the 90-day global period that should have been bundled, and claims that were not billed during the global period for services that qualified as distinct. Both categories represent either compliance risk or revenue left behind.
• Implant capture reconciliation: Cross-reference operating room (OR) logs against charge capture records for joint replacement and spine procedures. Implants appearing in the operative note but not in the billing record represent direct, recoverable revenue.
• Prior authorization denial rate by MA plan: Segment prior authorization denials by payer and procedure. High denial rates from specific MA plans for specific procedures point to authorization workflow gaps that payer-specific templates can close prospectively.
• Place-of-service accuracy review: Compare billed POS codes against actual care setting and payer-specific coverage rules. Systematic POS mismatches on ASC-performed procedures represent a predictable underpayment pattern that analytics can surface at scale.

At 3Gen Consulting, this assessment is the starting point for every orthopedic engagement – and for PE-backed groups, the findings are reported at the portfolio level with EBITDA impact quantified at your current multiple. RevGen-i provides the real-time analytics infrastructure that makes this assessment continuous, not a one-time exercise.

The evaluation criteria for orthopedic billing companies in a PE-backed context differ from those that a standalone practice applies. The questions that matter are not only about denial rates – they are about whether billing performance data is reportable in a format that connects to the financial metrics PE boards review.

Evaluate orthopedic billing partners on these criteria:

• Orthopedic-specific coding depth: coders with demonstrated expertise in CPT coding for joint replacement, spine, fracture care, and arthroscopy, not general surgical coding with orthopedic volume
• Global period and implant capture protocols: specific, documented workflows that operate at charge entry, not during billing review
• Payer-specific prior authorization templates: distinct authorization logic by procedure and MA plan, updated as payer requirements change
• TEAM Model billing alignment: understanding of how discharge coding and post-acute care documentation affect episode cost accountability for TEAM-participating hospitals
• Portfolio-level analytics reporting: performance data consolidated across multiple locations and payer contracts in a format that supports EBITDA reporting, not just AR management
• Revenue integrity, not just denial management: systematic identification of underpayments in paid claims, not only pursuit of unpaid ones

The orthopedic practices achieving best-in-class revenue cycle performance in 2026 treat billing infrastructure as a financial asset – one that is built, measured, and optimized with the same rigor as the clinical operation it supports.

If billing leakage is suppressing your practice's EBITDA, the recovery opportunity at current transaction multiples is larger than most billing conversations acknowledge. Quantify it with 3Gen.